Ozge Cevik

TRAIL PLGA/Gelucire 48/16 and exosome carrier systems enhance anti-tumor efficacy by enabling autophagic motility

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a potent anticancer protein that selectively reduces the viability of malignant cells but is limited clinically by its short half-life. This study developed novel TRAIL-loaded drug carrier systems to prolong its m...